A growing number of Ozempic and Mounjaro users have shared stark warnings after going blind while using GLP-1 drugs .

Now a new study is bringing into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

But despite seemingly alarming numbers, a doctor explained to The Post why she doesn’t actually think it should steer people away from the jab. 3

Published in JAMA Ophthalmology , the study was drawn from the health records of nearly 140,000 patients.

Researchers found that after one year, GLP-1 users were more than twice as likely to develop neovascular age-related macular degeneration than those who were not taking the drugs.

Age-related macular degeneration (AMD) is a disease that gradually damages the macula, the part of yo

See Full Page